Gen2 Neuroscience Company
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau.
Headquarters:
Manchester, Manchester, United Kingdom
Last Funding Type:
Seed
Investors Number:
1
Last Funding Date:
06-03-2016
Employee Number:
1-10
Founded Date:
2016
Industry:
NeuroTech
Funding Status:
Seed